MARKER THERAPEUTICS, INC. Foreign Currency Transaction Gain (Loss), before Tax
MARKER THERAPEUTICS, INC. (MRKR) reported Foreign Currency Transaction Gain (Loss), before Tax of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-14.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2017-03-14
- MARKER THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2016-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2016-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2015-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2015-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- MARKER THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2015 was $775.00.
- MARKER THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2014 was -$52.98K, a 998.51% decline from fiscal 2013.
- MARKER THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2013 was $5.90K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 143 month | Foreign Currency Transaction Gain (Loss), before Tax 146 month | Foreign Currency Transaction Gain (Loss), before Tax 149 month | Foreign Currency Transaction Gain (Loss), before Tax 152 month | Foreign Currency Transaction Gain (Loss), before Tax 155 month | Foreign Currency Transaction Gain (Loss), before Tax 161 month | Foreign Currency Transaction Gain (Loss), before Tax 164 month | Foreign Currency Transaction Gain (Loss), before Tax 167 month | Foreign Currency Transaction Gain (Loss), before Tax 170 month | Foreign Currency Transaction Gain (Loss), before Tax 173 month | Foreign Currency Transaction Gain (Loss), before Tax 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $0.00 derived: sum of 2 quarters · filed 2017-03-14 | $0.00 10-K · filed 2017-03-14 | ||||||||||||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-04 | $0.00 10-Q · filed 2016-11-04 | |||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $0.00 derived: sum of 2 quarters · filed 2017-03-14 | $775.00 derived: sum of 3 quarters · filed 2017-03-14 | $775.00 10-K · filed 2017-03-14 | |||||||||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-04 | $775.00 derived: sum of 2 quarters · filed 2016-11-04 | $775.00 10-Q · filed 2016-11-04 | ||||||||||||
| 2015-06-30 | $775.00 10-Q · filed 2016-08-15 | $775.00 10-Q · filed 2016-08-15 | |||||||||||||
| 2014-12-31 | -$52.98K 10-K · filed 2016-04-14 | ||||||||||||||
| 2014-06-30 | $51.58K 10-Q · filed 2014-08-18 | ||||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $0.00 derived: sum of 2 quarters · filed 2015-04-15 | -$6.64K derived: sum of 3 quarters · filed 2015-04-15 | $5.90K 10-K/A · filed 2014-04-17 | $51.58K 10-Q/A · filed 2014-05-21 | ||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | -$6.64K derived: sum of 2 quarters · filed 2014-11-19 | $5.90K 10-Q · filed 2014-11-19 | -$4.31K derived: sum of 4 quarters · filed 2014-11-19 | $51.58K 10-Q · filed 2013-11-19 | ||||||||||
| 2013-06-30 | -$6.64K 10-Q · filed 2014-08-18 | $5.90K 10-Q · filed 2014-08-18 | -$4.31K derived: sum of 3 quarters · filed 2014-08-18 | -$11.50K derived: sum of 4 quarters · filed 2014-08-18 | $51.58K 10-Q · filed 2013-08-19 | ||||||||||
| 2013-03-31 | $12.53K 10-Q/A · filed 2014-05-21 | $2.33K derived: sum of 2 quarters · filed 2014-05-21 | -$4.87K derived: sum of 3 quarters · filed 2014-05-21 | $12.41K derived: sum of 4 quarters · filed 2014-05-21 | $58.22K 10-Q/A · filed 2013-08-19 | ||||||||||
| 2012-12-31 | -$10.21K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | -$17.40K derived: sum of 2 quarters · filed 2013-11-19 | -$120.00 derived: sum of 3 quarters · filed 2013-11-19 | -$7.90K 10-K/A · filed 2014-04-17 | $45.69K 10-K · filed 2013-05-15 | ||||||||||
| 2012-09-30 | -$7.19K 10-Q · filed 2013-11-19 | $10.09K derived: sum of 2 quarters · filed 2013-11-19 | $2.30K 10-Q · filed 2013-11-19 | $12.83K derived: sum of 4 quarters · filed 2013-11-19 | |||||||||||
| 2012-06-30 | $17.28K 10-Q · filed 2013-08-19 | $9.50K 10-Q · filed 2013-08-19 | $20.03K derived: sum of 3 quarters · filed 2013-08-19 | $34.68K derived: sum of 4 quarters · filed 2013-08-19 | $63.09K 10-Q/A · filed 2012-09-12 | ||||||||||
| 2012-03-31 | -$7.78K 10-Q/A · filed 2013-08-19 | $2.75K derived: sum of 2 quarters · filed 2013-08-19 | $17.40K derived: sum of 3 quarters · filed 2013-08-19 | $10.49K derived: sum of 4 quarters · filed 2013-08-19 | $45.81K 10-Q · filed 2012-05-21 | ||||||||||
| 2011-12-31 | $10.53K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | $25.18K derived: sum of 2 quarters · filed 2013-05-15 | $18.28K derived: sum of 3 quarters · filed 2013-05-15 | $10.24K 10-K · filed 2013-05-15 | $53.59K 10-K · filed 2012-04-16 | ||||||||||
| 2011-09-30 | $14.65K 10-Q · filed 2011-11-21 | $7.75K derived: sum of 2 quarters · filed 2012-09-12 | -$293.00 10-Q · filed 2011-11-21 | $2.04K derived: sum of 4 quarters · filed 2012-09-12 | $43.06K 10-Q · filed 2011-11-21 | ||||||||||
| 2011-06-30 | -$6.91K 10-Q/A · filed 2012-09-12 | -$14.95K 10-Q/A · filed 2012-09-12 | -$12.61K derived: sum of 3 quarters · filed 2012-09-12 | -$14.63K derived: sum of 4 quarters · filed 2012-09-12 | $28.41K 10-Q · filed 2011-08-22 | ||||||||||
| 2011-03-31 | -$8.04K 10-Q · filed 2012-05-21 | -$5.71K derived: sum of 2 quarters · filed 2012-05-21 | -$7.73K derived: sum of 3 quarters · filed 2012-05-21 | -$4.80K derived: sum of 4 quarters · filed 2012-05-21 | |||||||||||
| 2010-12-31 | $2.34K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $314.00 derived: sum of 2 quarters · filed 2012-04-16 | $3.24K derived: sum of 3 quarters · filed 2012-04-16 | -$1.24K 10-K · filed 2012-04-16 | |||||||||||
| 2010-09-30 | -$2.02K 10-Q · filed 2011-11-21 | $907.00 derived: sum of 2 quarters · filed 2011-11-21 | -$3.57K 10-Q · filed 2011-11-21 | ||||||||||||
| 2010-06-30 | $2.93K 10-Q · filed 2011-08-22 | -$1.55K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |